ArticleBMC cancer2018

Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.

David A Bernal-Estévez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.